Literature DB >> 33402848

Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix.

Peng Gao1, Zhongzhao Wang1, Xiangyi Kong1, Xiangyu Wang1, Yi Fang1, Jing Wang1.   

Abstract

BACKGROUND: Biological matrix can provide coverage of compromised muscle and augment the subpectoral pocket in the one-stage reconstruction. However, few studies compared one stage implant-based breast reconstruction with and without biological matrix. The primary endpoint of our study was to assess the patient-reported outcomes (PROs) based on BREAST-Q version 2.0 and analyze complications between SIS matrix-assisted implant-based breast reconstruction (IBBR) and no-matrix-assisted IBBR.
METHODS: This retrospective single-center study was conducted from May 2015 to April 2019, and we analyzed 155 patients who underwent one-stage IBBR with at least 1 year of follow-up. Seventy-nine patients underwent one-stage IBBR with SIS matrix group and 76 patients underwent one-stage IBBR without SIS matrix group were evaluated of PROs with BREAST-Q version 2.0 (from 3 different domains) and compared with complications. Complications occurred in patients were divided into major complications and minor complications.
RESULTS: In the satisfaction domain, the mean score for satisfaction with breasts was 60.27 (17.71) in the SIS matrix group and 54.49 (14.76) in the no-matrix group, p=0.045. The multivariate logistic regression for postoperative complications in the whole series pointed out a statistical significance for age>40 years old (odds ratio 3.314, 95% CI 1.012-10.854, p=0.048) and patients with endocrine therapy (odds ratio 0.260, 95% CI 0.092-0.736, p=0.011).
CONCLUSION: Patients who underwent SIS matrix-assisted one-stage IBBR yield better results in PROs of satisfaction with breasts. Other domains and complications between the two groups had no significant difference.
© 2020 Gao et al.

Entities:  

Keywords:  BREAST-Q version 2.0; biological matrix; breast cancer; one-stage implant-based breast reconstruction

Year:  2020        PMID: 33402848      PMCID: PMC7778507          DOI: 10.2147/CMAR.S282442

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  36 in total

1.  Biological Matrices and Synthetic Meshes Used in Implant-based Breast Reconstruction - a Review of Products Available in Germany.

Authors:  M Dieterich; A Faridi
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-11       Impact factor: 2.915

2.  Comparative Study of Meshed and Nonmeshed Acellular Dermal Matrix in Immediate Breast Reconstruction.

Authors:  Adi Maisel Lotan; Dafna Ben Yehuda; Tanir M Allweis; Michael Scheflan
Journal:  Plast Reconstr Surg       Date:  2019-11       Impact factor: 4.730

3.  Nationwide trends in mastectomy for early-stage breast cancer.

Authors:  Kristy L Kummerow; Liping Du; David F Penson; Yu Shyr; Mary A Hooks
Journal:  JAMA Surg       Date:  2015-01       Impact factor: 14.766

Review 4.  Benefits and risks with acellular dermal matrix (ADM) and mesh support in immediate breast reconstruction: a systematic review and meta-analysis.

Authors:  Håkan Hallberg; Svanheidur Rafnsdottir; Gennaro Selvaggi; Annika Strandell; Ola Samuelsson; Ida Stadig; Therese Svanberg; Emma Hansson; Richard Lewin
Journal:  J Plast Surg Hand Surg       Date:  2018-01-10

5.  Does acellular dermal matrix really improve aesthetic outcome in tissue expander/implant-based breast reconstruction?

Authors:  Ahmed M S Ibrahim; Pieter G L Koolen; Oren Ganor; Mark K Markarian; Adam M Tobias; Bernard T Lee; Samuel J Lin; Marc A M Mureau
Journal:  Aesthetic Plast Surg       Date:  2015-04-17       Impact factor: 2.326

6.  Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre.

Authors:  M D Barber; L Williams; E D C Anderson; G T Neades; C Raine; O Young; D Kulkarni; I Young; J M Dixon
Journal:  Eur J Surg Oncol       Date:  2014-09-06       Impact factor: 4.424

7.  The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial.

Authors:  Colleen M McCarthy; Clara N Lee; Eric G Halvorson; Elyn Riedel; Andrea L Pusic; Babak J Mehrara; Joseph J Disa
Journal:  Plast Reconstr Surg       Date:  2012-11       Impact factor: 4.730

8.  Immediate breast reconstruction using porcine acellular dermal matrix (Strattice™): long-term outcomes and complications.

Authors:  C Andrew Salzberg; Courtney Dunavant; Nadia Nocera
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-11-13       Impact factor: 2.740

9.  Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial.

Authors:  D Gschwantler-Kaulich; P Schrenk; V Bjelic-Radisic; K Unterrieder; C Leser; A Fink-Retter; M Salama; C Singer
Journal:  Eur J Surg Oncol       Date:  2016-02-23       Impact factor: 4.424

10.  Initial experience with the use of foetal/neonatal bovine acellular dermal collagen matrix (SurgiMend™) for tissue-expander breast reconstruction.

Authors:  Rika Ohkuma; Kate J Buretta; Raja Mohan; Gedge D Rosson; Ariel N Rad
Journal:  J Plast Reconstr Aesthet Surg       Date:  2013-06-13       Impact factor: 2.740

View more
  2 in total

1.  Patient-Reported Outcomes and Complications Following Breast Reconstruction: A Comparison Between Biological Matrix-Assisted Direct-to-Implant and Latissimus Dorsi Flap.

Authors:  Peng Gao; Ping Bai; Xiangyi Kong; Yi Fang; Jidong Gao; Jing Wang
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  Biological Matrix-Assisted One-Stage Implant-Based Breast Reconstruction Versus Two-Stage Implant-Based Breast Reconstruction: Patient-Reported Outcomes and Complications.

Authors:  Peng Gao; Ping Bai; Yinpeng Ren; Xiangyi Kong; Zhongzhao Wang; Yi Fang; Jing Wang
Journal:  Aesthetic Plast Surg       Date:  2021-08-04       Impact factor: 2.326

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.